Immuneering Corporation News, Immuneering Corporation Quote, IMRX Quote

Immuneering Corporation (NQ:IMRX) Delayed: 4.46 +0.17 (3.96%)

Prev. Close

$4.29

Today 6M 1Y 5Y

Open

$4.30

52 Wk High

$0.04

52 Wk Low

$0.00

Day High

$4.51

Day Low

$4.27

P/E

N/A

EPS

$-0.09

Volume

759,522

Friends, Peers and Foes (?): TEVA, LLY, ONCY, ALXO, ERAS (more...)

ALERTS | RSS

Jul 21, 2026 04:06 PM Immuneering publishes preclinical data on atebimetinib in Cancer Research
Jul 21, 2026 04:05 PM Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
Jul 17, 2026 04:29 PM Form 4 Immuneering Corp For: Jul 16 Filed by: Gengos Andrew
Jul 17, 2026 04:05 PM Immuneering Corporation Announces Grants of Inducement Awards
Jul 16, 2026 04:11 PM Form 3 Immuneering Corp For: Jul 16 Filed by: Gengos Andrew
Jul 8, 2026 02:34 PM Immuneering Corporation (IMRX) 7500 contracts of August 75 calls as share price up 6.2%
Jul 8, 2026 06:06 AM Cantor Fitzgerald Starts Immuneering Corporation (IMRX) at Overweight
Jul 6, 2026 04:05 PM Kalaris Therapeutics names Laurie Keating to its board
Jun 24, 2026 04:11 PM Form 4 Immuneering Corp For: Jun 23 Filed by: Zeskind Benjamin J.
Jun 16, 2026 04:15 PM Form 4 Immuneering Corp For: Jun 15 Filed by: Hall Brett Matthew

Entities mentioned with IMRX

View All Entities